ClinicalTrials.Veeva
Menu

Find clinical trials for Diabetes in Nashville, TN

CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones

Related conditions:

Type 2 Diabetes Mellitus
Diabetes Mellitus
Obesity
Type 1 Diabetes Mellitus
Overweight
Diabetic Foot
Foot Ulcer

Diabetes trials near Nashville, TN, USA:

Teplizumab in Pediatric Stage 2 Type 1 Diabetes (PETITE-T1D)

The purpose of this study is to assess the safety and pharmacokinetics (PK) of teplizumab in participants with Stage 2 type 1 diabetes who a...

Active, not recruiting
Diabetes Mellitus, Type 1
Biological: teplizumab

Phase 4

Sanofi
Sanofi

Nashville, Tennessee, United States and 9 other locations

The central hypothesis is that inflammation mediators are biomarkers of both systemic diabetes and Diabetic Retinopathy (DR) progre...

Active, not recruiting
Diabetic Retinopathy
Drug: Ketorolac 0.45% ophthalmic solution
Drug: Placebo - Preservative-free artificial tears

Phase 1

Stephen J. Kim, MD

Nashville, Tennessee, United States

The main purpose of this study is to learn more about the safety and efficacy of investigational tirzepatide doses in participants with Type 2 diabetes...

Active, not recruiting
Type 2 Diabetes
Obesity
Drug: Tirzepatide
Drug: Placebo

Phase 2

Lilly
Lilly

Nashville, Tennessee, United States and 40 other locations

The purpose of this study is to assess the safety and efficacy of up to 2 REACT/rilparencel injections in participants with T2DM and CKD.

Enrolling
Type 2 Diabetes Mellitus
Chronic Kidney Diseases
Biological: Renal Autologous Cell Therapy (REACT/ rilparencel)
Procedure: Sham Comparator

Phase 3

Prokidney

Nashville, Tennessee, United States and 96 other locations

New

in pediatric participants aged 10 to less than 18 years with type 2 diabetes. The study will also check how safe these medicines are and how...

Begins enrollment in 2 months
Diabetes Mellitus, Type 2
Drug: Orforglipron
Drug: Dulaglutide

Phase 3

Lilly
Lilly

Nashville, Tennessee, United States and 70 other locations

study medicine to help adults with obesity or overweight and type 2 diabetes lose weight. Being overweight or obese means carrying too much ...

Enrolling
Diabetes, Type 2
Type 2 Diabetes
Drug: PF-08653944
Other: Placebo

Phase 3

Pfizer
Pfizer

Goodlettsville, Tennessee, United States and 182 other locations

This is randomized, double-blind, placebo-controlled study of the long-term efficacy, safety, and tolerability of multiple doses of aleniglipron in p...

Begins enrollment this month
Type2 Diabetes Mellitus
Overweight
Drug: Placebo
Drug: aleniglipron

Phase 3

Gasherbrum Bio, Inc., a wholly owned subsidiary of Structure Therapeutics

Nashville, Tennessee, United States and 73 other locations

control clinical trial testing two different JAK Inhibitors abrocitnib, ritlecitinib, and placebo in subjects with recent onset Stage 3 Type 1 Diabetes...

Active, not recruiting
Diabetes Mellitus, Type 1
Drug: Ritlecitinib
Drug: Abrocitinib 200 MG Oral Tablet

Phase 2

National Institutes of Health (NIH)
National Institutes of Health (NIH)

Nashville, Tennessee, United States and 29 other locations

This study will look at the long-term effects of semaglutide (active medicine) on diabetic eye disease when compared to placebo (dummy medic...

Active, not recruiting
Diabetes Mellitus, Type 2
Drug: Semaglutide
Drug: Placebo (semaglutide)

Phase 3

Novo Nordisk
Novo Nordisk

Nashville, Tennessee, United States and 228 other locations

the treatment with the COMS One device in subjects with refractory diabetic foot ulcers (DFUs). The prospective randomized, double-blinded, ...

Enrolling
Diabetic Foot Ulcer
Device: COMS One device
Device: Sham device
Piomic Medical

Nashville, Tennessee, United States and 28 other locations

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems